Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01849874
Title A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Array BioPharma
Indications

ovarian carcinoma

peritoneal carcinoma

fallopian tube carcinoma

Therapies

Binimetinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.